Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 230

1.

Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis.

Zhang HC, Wang N, Zhang W, Gu ZC, Liu XY.

Medicine (Baltimore). 2018 Sep;97(36):e12203. doi: 10.1097/MD.0000000000012203. Review.

2.

Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies.

Shen L, Zhang C, Gu ZC, Lin HW, Liu XY, Pu J.

Medicine (Baltimore). 2018 Aug;97(34):e12072. doi: 10.1097/MD.0000000000012072. Review.

3.

Patent foramen ovale closure or medical therapy for secondary prevention of cryptogenic stroke: An update meta-analysis of randomized controlled trials.

Ma Y, Li D, Bai F, Qin F, Li J, Li Y, Liu N, Xie H, Zhou S, Liu Q.

Medicine (Baltimore). 2018 Aug;97(34):e11965. doi: 10.1097/MD.0000000000011965. Review.

4.

Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Jonas DE, Kahwati LC, Yun JDY, Middleton JC, Coker-Schwimmer M, Asher GN.

JAMA. 2018 Aug 7;320(5):485-498. doi: 10.1001/jama.2018.4190. Review.

PMID:
30088015
5.

Prognostic role of D-dimer level upon admission in patients with traumatic brain injury.

Zhang J, He M, Song Y, Xu J.

Medicine (Baltimore). 2018 Aug;97(31):e11774. doi: 10.1097/MD.0000000000011774. Review.

6.

Clinical Challenges of Using Novel Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation.

Nazeri A.

Tex Heart Inst J. 2018 Jun 1;45(3):164-165. doi: 10.14503/THIJ-18-6678. eCollection 2018 Jun. Review. No abstract available.

7.

Anticoagulation Reversal.

Simon EM, Streitz MJ, Sessions DJ, Kaide CG.

Emerg Med Clin North Am. 2018 Aug;36(3):585-601. doi: 10.1016/j.emc.2018.04.014. Review.

PMID:
30037445
8.

Acute non-cirrhotic portal vein thrombosis : review.

Salembier A, Verhamme M, Verhamme P, Van Moerkercke W.

Acta Gastroenterol Belg. 2018 Apr-Jun;81(2):318-322. Review.

PMID:
30024704
9.

An evaluation of the pharmacotherapy for interstitial cystitis.

Giusto LL, Zahner PM, Shoskes DA.

Expert Opin Pharmacother. 2018 Jul;19(10):1097-1108. doi: 10.1080/14656566.2018.1491968. Epub 2018 Jul 4. Review.

PMID:
29972328
10.

Rivaroxaban: searching the integral vascular protection.

Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazón P, Camafort M, Cepeda JM, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C.

Expert Rev Clin Pharmacol. 2018 Jul;11(7):719-728. doi: 10.1080/17512433.2018.1495559. Epub 2018 Jul 18. Review.

PMID:
29965791
11.

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 19;6:CD006650. doi: 10.1002/14651858.CD006650.pub5. Review.

PMID:
29920657
12.

Antithrombotic Therapy for Peripheral Artery Disease in 2018.

Hess CN, Hiatt WR.

JAMA. 2018 Jun 12;319(22):2329-2330. doi: 10.1001/jama.2018.5422. Review. No abstract available.

PMID:
29860284
13.

Anticoagulation for people with cancer and central venous catheters.

Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, Terrenato I, Sperati F, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 1;6:CD006468. doi: 10.1002/14651858.CD006468.pub6. Review.

PMID:
29856471
14.

Managing comorbid cardiovascular disease and sleep apnea with pharmacotherapy.

Wolf J, Narkiewicz K.

Expert Opin Pharmacother. 2018 Jun;19(9):961-969. doi: 10.1080/14656566.2018.1476489. Epub 2018 May 24. Review.

PMID:
29792524
15.

Diagnosis and Management of the Antiphospholipid Syndrome.

Garcia D, Erkan D.

N Engl J Med. 2018 May 24;378(21):2010-2021. doi: 10.1056/NEJMra1705454. Review. No abstract available.

PMID:
29791828
16.

Concerns for Bleeding in the Elderly with the Use of Direct Oral Anticoagulants.

Min M, Sibicky S.

Consult Pharm. 2018 May 1;33(5):262-267. doi: 10.4140/TCP.n.2018.262.. Review.

PMID:
29789047
17.

Management of Venous Thromboembolism in the Elderly: A Review of the Non-Vitamin K Oral Anticoagulants.

Bethishou L, Gregorian T, Won K, Lopez K, Tsu LV.

Consult Pharm. 2018 May 1;33(5):248-261. doi: 10.4140/TCP.n.2018.248.. Review.

PMID:
29789046
18.

Management of venous thromboembolism with non-vitamin K oral anticoagulants: A review for nurse practitioners and pharmacists.

Schmerge M, Earl S, Kline C.

J Am Assoc Nurse Pract. 2018 Apr;30(4):185-192. doi: 10.1097/JXX.0000000000000043. Review.

PMID:
29757786
19.

Approaches to Left Atrial Appendage Closure: Device Design, Performance, and Limitations.

Dave AS, Valderrábano M.

Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):106-113. doi: 10.14797/mdcj-13-3-106. Review.

20.

Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults.

Hasan SS, Kow CS, Curley LE, Baines DL, Babar ZU.

Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):371-377. doi: 10.1080/14737167.2018.1474101. Epub 2018 May 9. Review.

PMID:
29741099

Supplemental Content

Loading ...
Support Center